Amneal Pharmaceuticals Inc Class A (AMRX)
Income Tax Expense
-$14.14M
TTM · Period ending: · USD
AMRX Income Tax Expense
Latest reported-$14.14Mperiod ending
Latest reported-$14.14Mperiod ending
AMRX TTM Income Tax ($2.00M → -$14.14M)
TTM income tax expense
High-resolution chart · PNG
AMRX income tax expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Income Tax Expense (USD) |
|---|---|
| -14,141,000 | |
| 584,000 | |
| 11,276,000 | |
| 11,037,000 | |
| 38,058,000 | |
| 25,575,000 | |
| 18,863,000 | |
| 23,323,000 | |
| 17,581,000 | |
| 13,940,000 | |
| 8,452,000 | |
| -3,228,000 | |
| 3,418,000 | |
| 10,791,000 | |
| 6,662,000 | |
| 12,599,000 | |
| 12,078,000 | |
| 7,376,000 | |
| 11,196,000 | |
| 8,541,000 | |
| 4,636,000 | |
| 4,174,000 | |
| -104,358,000 | |
| -98,051,000 | |
| 291,473,000 | |
| 283,586,000 | |
| 383,331,000 | |
| 381,063,000 | |
| -3,496,000 | |
| -10,211,000 | |
| -1,419,000 | |
| -7,062,000 | |
| -12,909,000 | |
| 1,359,000 | |
| 1,998,000 | |
| 3,667,000 |